AstraZeneca’s Alexion creates interactive fantasy storybook to help kids with aHUS understand rare kidney disease
To guide children through an atypical hemolytic uremic syndrome diagnosis and subsequent treatment, Alexion Pharmaceuticals has released an interactive storybook aimed at “demystifying” the disease for 6- to 10-year-olds.
To guide children through an atypical hemolytic uremic syndrome diagnosis and subsequent treatment, Alexion Pharmaceuticals has released an interactive storybook aimed at “demystifying” the disease for 6- to 10-year-olds.
